Education
About Us
Working with TipRanks
Follow Us
EIS - ETF AI Analysis
Top Page
iShares MSCI Israel ETF (EIS)
Rating:59Neutral
Price Target:―
Positive Factors
Recent Performance Momentum
The ETF has shown solid gains over the past three months and year-to-date, indicating positive recent momentum.
Strong Leading Holdings
Several of the largest positions, including major banks, defense, and semiconductor companies, have delivered strong performance, supporting the fund’s overall returns.
Sector Diversification Within Israel
Holdings spread across financials, technology, health care, real estate, and other sectors help reduce the impact of weakness in any single industry.
Negative Factors
High Country Concentration
The fund is heavily focused on Israel, so its performance is closely tied to the economic and geopolitical conditions of a single country.
Financial Sector Dominance
A large share of assets in financial stocks means the ETF is especially sensitive to the health of Israel’s banking and financial system.
Relatively High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which can modestly reduce investors’ net returns over time.
EIS vs. SPDR S&P 500 ETF (SPY)
AUM832.05M
RegionMiddle East & Africa
Expense Ratio0.59%
Beta0.76
IssueriShares
Inception DateMar 26, 2008
Dividend Yield1.29%
Asset ClassEquity
Index TrackedMSCI Israel Capped Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume136,732
30 Day Avg. Volume105,686
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EIS Summary
The iShares MSCI Israel ETF (EIS) tracks the MSCI Israel Capped Index, giving you broad exposure to companies tied to Israel’s stock market. It holds a mix of banks, technology, healthcare, and industrial firms, including well-known names like Teva Pharmaceutical and CyberArk Software. Investors might consider EIS to diversify internationally and tap into Israel’s reputation for innovation and tech-driven growth, all in a single fund. However, this ETF is focused on one small country and is heavily tilted toward financial and tech stocks, so its price can move up and down sharply with news and market swings in that region.
How much will it cost me?The iShares MSCI Israel ETF (EIS) has an expense ratio of 0.59%, meaning you’ll pay $5.90 per year for every $1,000 invested. This is higher than average for ETFs because it is passively managed but focuses on a niche market, which can involve higher costs to track the index effectively.
What would affect this ETF?The iShares MSCI Israel ETF (EIS) could benefit from Israel's strong presence in technology and healthcare, sectors known for innovation and growth potential. However, challenges such as geopolitical tensions in the Middle East or changes in global interest rates affecting financial institutions could negatively impact the ETF's performance. Investors should also consider how broader economic conditions and regulatory changes in Israel might influence its top holdings, including major banks and tech companies.
EIS Top 10 Holdings
EIS is leaning heavily on Israel’s big banks, with Leumi, Poalim, Discount, and Mizrahi Tefahot all rising and effectively steering the fund’s performance from the financial driver’s seat. On the growth side, Tower and Nova have been standout climbers, giving the portfolio a tech-powered boost, while defense contractor Elbit Systems has also been a strong tailwind. In contrast, cybersecurity names like CyberArk and Check Point are losing steam, creating a bit of drag. Overall, this is a tightly focused, Israel-only bet on financial strength and selective tech momentum.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Teva Pharmaceutical | 9.32% | $80.14M | $39.38B | 109.11% | 63 Neutral | |
| Leumi | 9.11% | $78.32M | ₪116.99B | 93.46% | 80 Outperform | |
| Poalim | 8.03% | $69.07M | ₪108.92B | 96.78% | 79 Outperform | |
| Elbit Systems | 4.47% | $38.41M | ₪96.79B | 127.77% | 73 Outperform | |
| Discount | 3.85% | $33.07M | ₪49.62B | 73.53% | 75 Outperform | |
| Tower | 3.64% | $31.27M | ₪44.47B | 170.29% | ― | |
| Check Point | 3.52% | $30.29M | $18.41B | -22.79% | 76 Outperform | |
| Nova | 3.20% | $27.47M | ₪41.86B | 65.60% | ― | |
| Mizrahi Tefahot | 3.10% | $26.62M | ₪66.60B | 143.80% | 80 Outperform | |
| Phoenix | 3.00% | $25.77M | ₪42.81B | 175.95% | 79 Outperform |
EIS Technical Analysis
Positive
―
Price Trends
115.27
Positive
107.68
Positive
98.30
Positive
Market Momentum
2.11
Positive
63.74
Neutral
75.47
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EIS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 120.28, equal to the 50-day MA of 115.27, and equal to the 200-day MA of 98.30, indicating a bullish trend. The MACD of 2.11 indicates Positive momentum. The RSI at 63.74 is Neutral, neither overbought nor oversold. The STOCH value of 75.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for EIS.
EIS Peer Comparison
Comparison Results
Performance Comparison
EIS
iShares MSCI Israel ETF
122.50
40.15
48.76%
WCMI
First Trust WCM International Equity ETF
―
―
―
FLGB
Franklin FTSE United Kingdom ETF
―
―
―
IDVO
Amplify International Enhanced Dividend Income ETF
―
―
―
SEIE
SEI Select International Equity ETF
―
―
―
ISRA
VanEck Israel ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents